MapLight Therapeutics elects three directors, ratifies RSM US LLP as auditor

MapLight Therapeutics, Inc.

Martin Babler, Troy Cox, George Pavlov elected as directors with 89.8%, 99.9%, 97.8% of votes cast.
Ratification of RSM US LLP as independent auditor approved with 99.9% of votes (36,859,217 for, 22,332 against).
Turnout: 36,883,750 shares (86.56% of outstanding) present or represented at June 23, 2026 annual meeting.
Broker non-votes on director election: 1,883,819 shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.